Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
≤,32252763,MICs,"We identified several compounds with MICs ≤25 μM against M. pulmonis (n = 5), M. capricolum (n = 4), M. gallisepticum (n = 3), M. alligatoris (n = 3), M. agassizii (n = 2), and M. canis (n = 1).",Efficacy data of halogenated phenazine and quinoline agents and an NH125 analogue to veterinary mycoplasmas. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32252763/),μM,25,67184,DB01422,Nitroxoline
≤,32252763,MIC,"An N-arylated NH125 analogue, compound 21, served as the most efficacious, having a MIC ≤25 μM against all mycoplasmas tested, followed by two quinolines, nitroxoline (compound 12) and compound 20, which were effective against four and three mycoplasma type strains, respectively.",Efficacy data of halogenated phenazine and quinoline agents and an NH125 analogue to veterinary mycoplasmas. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/32252763/),μM,25,67185,DB01422,Nitroxoline
,3309832,Tmax,"2) Despite individual variations due to oral administration, pharmacokinetic parameters could be calculated: Tmax: 1.75 +/- 1.04 h; Cmax: 5.59 +/- 3.15 mg/l; t 1/2 beta: 2.63 +/- 2.66 h.",[Present status of nitroxoline]. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3309832/),h,1.75,159623,DB01422,Nitroxoline
,3309832,Cmax,"2) Despite individual variations due to oral administration, pharmacokinetic parameters could be calculated: Tmax: 1.75 +/- 1.04 h; Cmax: 5.59 +/- 3.15 mg/l; t 1/2 beta: 2.63 +/- 2.66 h.",[Present status of nitroxoline]. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3309832/),[mg] / [l],5.59,159624,DB01422,Nitroxoline
,3309832,t 1/2 beta,"2) Despite individual variations due to oral administration, pharmacokinetic parameters could be calculated: Tmax: 1.75 +/- 1.04 h; Cmax: 5.59 +/- 3.15 mg/l; t 1/2 beta: 2.63 +/- 2.66 h.",[Present status of nitroxoline]. ,"t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3309832/),h,2.63,159625,DB01422,Nitroxoline
